Trast patch and Ginexin F tab won the grand award of 2008 Korea’s representative brand.
- Selected as the Korea’s representative brand directly by 1.98 million consumers
- Trast wining an award in consecutive 2 years, reminding us of Trast when it comes to knees
- Ginexin F, green ginkgo leaves, making blood clean and blood vessels robust

SK chemicals’ Trast patch(hereinafter “Trast”), a knee arthritis medicine, and Ginexin F tab (hereinafter “Ginexin F”), a blood circulation improvement medicine, proved themselves to be Korean’s representative brands by wining [2008 Korea’s representative brand award].

[2008 Korea’s representative brand award] is selected through direct internet votes in which 16 or more years old consumers participate directly as well as through advance basic survey such as revenue amount, market share rate, etc., having a big meaning in that it is a representative brand picked directly by consumers.

Trast was selected as a representative brand in the arthritis medicine part in consecutive 2 years while showing 38% approval rating among 1,983,846 votes of total survey cases as a result of internet voting, and Ginexin F was selected as a representative brand in the blood circulation improvement medicine part by obtaining 39% approval rating.

In-Seok Lee, marketing headquarters manager of SK chemicals, attending the awarding ceremony, expressed his impressions on awarding, “this has a much bigger meaning because it is a representative brand award picked directly y consumers, so we will be making SK chemicals’ all brands a representative brand through consistent control of brands.”

Trast and Ginexin F have settled down as Korea’s representative brands because there have been SK chemicals’ consistent brand control efforts.

Trast patch, starting to be sold in 1996, has attracted industry’s unusual interest by achieving 10 billion won of revenue, a big record, in the first year of sales through a breakthrough of 1 million sets of sales amount in 3 month of showing up in the market. It was a major success strategy to focus on ‘knees’ among various arthritis.

Brand image differentiation as well as product differentiation from rival products advertised as ‘arthritis medicines,’ owing to a specific and frank advertisement concept called ‘also Trast for knees.’

Ginexin F, a blood circulation improvement medicine of green ginkgo leaves, is a blood circulation improvement medicine made of 100% ginkgo leave extracts which has been developed by SK chemicals Life Science Research Institute in 1992 through its independent technology.

Ginexin F reduces blood viscosity through a blood platelet cohesion suppression effect, and improves bloodstream through a blood vessel expansion effect and an anti-oxidation effect. That is, this makes bloodstream smooth by making blood clean and by broadening blood vessels.

Besides, the anti-oxidant action of ginkgo leaves makes the flow of acetylcholine, brain’s major neurotransmitter, smooth by protecting brain cells and nerve cells through a cell protection effect.

Ginexin F shows an excellent effect in the treatment of the recognition ability drop in vascular dementia and altzheimer’s dementia and the treatment of headache, tinnitus, dizziness, vertigo, short-term amnesia, depression, etc. caused by the dysfunction of brain bloodstream, owing to a medical action in two aspects such as blood circulation improvement and cell protection effects.

The excellent blood circulation improvement effect helps prevent reoccurrence of cerebral apoplexy by reducing abnormally high blood viscosity which appears to cerebral apoplexy patients.

SK chemicals’ Ginexin F has settled down as the 1st ranking brand in the blood circulation improvement medicine part of ginkgo leaves by strengthening its brand power continuously in the domestic market since its first showing up in the market in 1992 based on such a differentiated medical efficacy.